Literature DB >> 12077369

Ca2+-induced changes in SNAREs and synaptotagmin I correlate with triggered exocytosis from chromaffin cells: insights gleaned into the signal transduction using trypsin and botulinum toxins.

Gary W Lawrence1, J Oliver Dolly.   

Abstract

Ca2+-triggered catecholamine exocytosis from chromaffin cells involves SNAP-25, synaptobrevin and syntaxin (known as SNAREs). Synaptotagmin I has been implicated as the Ca2+-sensor because it binds Ca2+, and this enhances its binding to syntaxin, SNAP-25 and phospholipids in vitro. However, most of these interactions are only mediated by [Ca2+]i two orders of magnitude higher than that needed to elicit secretion. Thus, the Ca2+ sensitivities of synaptotagmin I and the other SNAREs were quantified in situ. Secretion elicited from permeabilised cells by microM Ca2+ was accompanied, with almost identical Ca2+ dependencies, by changes in synaptotagmin I, SNAP-25, syntaxin and synaptobrevin that rendered them less susceptible to trypsin. The majority of the trypsin-resistant SNAREs were not associated with SDS-resistant complexes. None of these proteins acquired trypsin resistance in cells rendered incompetent for exocytosis by run-down. Removal of nine C-terminal residues from SNAP-25 by botulinum toxin A reduced both exocytosis and the SNAREs' acquisition of trypsin resistance but did not alter the Ca2+ sensitivity, except for synaptotagmin I. Even after synaptobrevin had been cleaved by botulinum toxin B, all the other proteins still responded to Ca2+. These data support a model whereby Ca2+ is sensed, probably by synaptotagmin I, and the signal passed to syntaxin and SNAP-25 before they interact with synaptobrevin.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12077369     DOI: 10.1242/jcs.115.13.2791

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  4 in total

1.  Inhibition of botulinum neurotoxin a toxic action in vivo by synthetic synaptosome- and blocking antibody-binding regions.

Authors:  M Zouhair Atassi; Behzod Z Dolimbek; Lance E Steward; K Roger Aoki
Journal:  Protein J       Date:  2010-07       Impact factor: 2.371

2.  A dileucine in the protease of botulinum toxin A underlies its long-lived neuroparalysis: transfer of longevity to a novel potential therapeutic.

Authors:  Jiafu Wang; Tomas H Zurawski; Jianghui Meng; Gary Lawrence; Weredeselam M Olango; David P Finn; Larry Wheeler; J Oliver Dolly
Journal:  J Biol Chem       Date:  2010-12-07       Impact factor: 5.157

3.  Exploding vs. imploding headache in migraine prophylaxis with Botulinum Toxin A.

Authors:  Moshe Jakubowski; Peter J McAllister; Zahid H Bajwa; Thomas N Ward; Patty Smith; Rami Burstein
Journal:  Pain       Date:  2006-10-25       Impact factor: 7.926

4.  Syntaxin-17 delivers PINK1/parkin-dependent mitochondrial vesicles to the endolysosomal system.

Authors:  Gian-Luca McLelland; Sydney A Lee; Heidi M McBride; Edward A Fon
Journal:  J Cell Biol       Date:  2016-07-25       Impact factor: 10.539

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.